Interestingly, MELK has also emerged as a potential target in cancer research as its expression is significantly elevated in many different tumors, such as glioblastoma [12], melanoma [13], breast [14], prostate [15], and renal cancer [16]. The gene discussed is MELK; the disease is melanoma.